Aushon Biosystems Thrives with Increasing Demand for Personalized Medicine
Wednesday, February 27, 2013
Adds former LabCorp leader Thomas Mac Mahon to board of directors, expects further growth in 2013.
Cancer Genetics, Inc. Receives Regulatory Approvals for MatBA®-DLBCL
Wednesday, February 27, 2013
MatBA®-DLBCL is a proprietary microarray test for the diagnosis, prognosis, and patient risk stratification of non-Hodgkin Lymphoma.
Flipping the 'Off' Switch on Cell Growth
Wednesday, February 27, 2013
Protein uses multiple means to help cells cope when oxygen runs low.
Lab21 and IntegraGen Partner to Develop New Colorectal Cancer Diagnostic
Tuesday, February 26, 2013
Lab21 to develop a CE marked assay to detect expression levels of a microRNA biomarker.
Abbott to Collaborate with Janssen and Pharmacyclics
Monday, February 25, 2013
Companies partner on development of companion test for investigational leukemia therapy.
'NanoVelcro' Device Grabs Single Cancer Cells From Blood
Monday, February 25, 2013
Researchers report that they have refined a method they previously developed for capturing and analyzing cancer cells that break away from patients' tumors and circulate in the blood.
Gallo Center Scientists Identify Potential New Mechanism for Treating Problem Drinking
Monday, February 25, 2013
Researchers identified a potential new approach for reducing problem drinking: a new family of drugs with the ability to manipulate DNA structure without changing it.
Companies Forge Huntington’s Disease Therapeutic and Companion Biomarker Collaboration
Friday, February 22, 2013
KineMed, Isis and CHDI collaborate to advance therapeutic development for Huntington’s disease and develop novel biomarkers for pre-clinical and clinical use in drug development and therapeutic monitoring.
When It Comes to Genetic Code, Optimum Isn't Always Best
Friday, February 22, 2013
Imagine two steel springs identical in look and composition but that perform differently because each was tempered at a different rate.
|
|
|
|
|
|
